NuNerve, a company formed to commercialise research from UQ’s Queensland Brain Institute, has produced successful results in a human clinical trial for potential new treatment for MND.
A collaboration between The University of Queensland (UQ) and the Queensland Emory Drug Discovery Initiative (QEDDI) has received a $550,000 FightMND grant to create and test new molecules for motor neurone disease (MND) treatment.
University of Queensland (UQ) researcher Dr Margreet Ridder has been named the inaugural Dr Ian Davis OAM Award recipient for the 2024 top-ranked FightMND project.
Dr Rebecca San Gil has mapped out the proteins implicated in MND across the trajectory of the disease, identifying potential therapeutic pathways for further investigation.
The Queensland Brain Institute (QBI) is proud to announce a $1 million gift today from FightMND to help fund a study on whether changes in the make-up of nerves are involved in causing neurodegeneration in MND.
Research at The University of Queensland could eventually help develop viable treatments - and ultimately a cure - for motor neurone disease (MND). Dr Adam Walker and co-authors from QBI have identified biochemical changes in a protein that is affected by MND.
Unlocking the mystery behind the catastrophic death of nerve cells in neurodegenerative disease is driving the fight against motor neuron disease (MND) and frontotemporal dementia.
Generous support from FightMND will allow QBI researchers to conduct a clinical trial, identify new drug targets, and progress towards personalised treatments for motor neurone disease (MND).
